#NASDAQ #Canada #Aurora Cannabis #Edmonton #medical cannabis

Aurora Cannabis to Ring Nasdaq Closing Bell

Aurora Cannabis Inc., a prominent player in the medical cannabis industry, will mark a significant milestone by ringing the Nasdaq closing bell on February 18, 2026, at the Nasdaq MarketSite in the heart of New York's Times Square. This event represents an essential celebration of Aurora's strategic focus on enhancing its global presence in the medical cannabis sector.

The ceremony will be led by Miguel Martin, the CEO and Executive Chairman of Aurora, along with an esteemed representative of the Board of Directors, and other key members of the executive leadership team. This gathering symbolizes not just a moment of pride for the company, but also a testament to its ongoing dedication to the medical cannabis community and its commitment to improving patient care around the world.

Aurora's Growth and Global Strategy

Miguel Martin emphasized the importance of this event, stating, "As we advance our global medical strategy, this moment at Nasdaq underscores our longstanding commitment to serving patients worldwide." This statement reflects Aurora's mission to position itself as a leader in medical-first cannabis production, focusing on high-margin opportunities in key international markets.

Aurora's past achievements and future prospects are rooted in a clear growth trajectory that pivots on innovation and compliance. As the company expands its reach into medical markets across regions such as Canada, Europe, Australia, and New Zealand, it focuses on providing consistently high-quality cannabis products to enhance the lives of patients. Aurora's expanding portfolio includes trusted brands like Aurora®, MedReleaf®, and Pedanios®, among others.

Live Broadcast and Community Engagement

The Nasdaq closing bell ceremony will commence at 3:45 PM ET, with the bell-ringing scheduled for 4:00 PM ET. The event will be streamed live across various Nasdaq channels, allowing audiences worldwide to partake in the celebration. To view the live broadcast, interested viewers can visit the Nasdaq MarketSite.

The significance of ringing the Nasdaq bell is monumental, as it highlights not only the company's success but also its collaborative vision to reshape the medical cannabis landscape. By advancing its strategies and reinforcing its commitment to high standards, Aurora aims to open new doors within the international cannabis community.

About Aurora Cannabis

Aurora is recognized as a global leader in the medical cannabis field, rooted in a mission to improve lives through scientific integrity and patient-centered care. With a remarkable compliance record and world-class manufacturing facilities based in Canada and Germany, Aurora's strategies are designed to hold strong positions in burgeoning international markets.

The company has dedicated itself to enhancing the global medical landscape through innovative solutions, ecological commitment, and a dedication to sustainability. By focusing on superior patient care and continuous research, Aurora intends to redefine the standards of medical cannabis.

With its wide array of products and innovative approach, Aurora Cannabis is poised to continue expanding its influence and reach, paving the way for healthier futures for patients around the globe. Stay updated on Aurora's journey by following them on social media platforms like X and LinkedIn.